Results 201 to 210 of about 168,707,534 (305)

Mode of action of chloroquine and related drugs

Memorias do Instituto Oswaldo Cruz, 1986
Coy D. Fitch, Phitsamai Kanjananggulpan, Jozef S. Mruk   +2 more
doaj   +1 more source

Emodepside: the anthelmintic's mode of action and toxicity. [PDF]

Front Parasitol
Njeshi CN, Robertson AP, Martin RJ.
europepmc   +1 more source

PANoptosis in the pathogenesis of myelodysplastic syndromes

Molecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang   +4 more
wiley   +1 more source

Metabolism and mode of action of gentian violet

Memorias do Instituto Oswaldo Cruz, 1988
Silvia N. J. Moreno
doaj   +1 more source

Mode of action of a DCAF16-recruiting targeted glue that can selectively degrade BRD9. [PDF]

Nat Commun
Hughes SJ, Stec WJ, Davies CTR, McGarry D, Williams A, Carrara M, Del Barco Barrantes I, Harris R, Tasegian A, Owens DDG, Fawcett A, Hellicar J, Azevedo A, Meier GP, Runcie AC, Greger L, O'Rourke M, Churcher I, Pass M, Brown GA, Ciulli A, Modis LK, Testa A.   +22 more
europepmc   +1 more source

Mode of Action of Sulphones

Japanese journal of leprosy, 1984
openaire   +3 more sources

Spatial biology in cancer epigenetics

Molecular Oncology, EarlyView.
Spatial epigenomics combines molecular profiling with tissue architecture to reveal how gene regulation is organized within intact tissues. In cancer, these technologies uncover the mechanisms driving tumor heterogeneity and microenvironmental interactions, opening new opportunities for biomarker discovery and precision medicine.
Eva Crespo‐García, Manel Esteller
wiley   +1 more source

Mode of action of methyldopa

Journal of Pharmacy and Pharmacology, 1967
M D, Day, M J, Rand
openaire   +2 more sources

Somatostatin receptor 4 (SSTR4) is a tumor suppressor in cutaneous and head & neck squamous cell carcinomas

Molecular Oncology, EarlyView.
This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi, Tuan Khang Huynh, Adway Kadam, Zahra Kardan, Yue Yan, Amina Jamal Laham, Sampath Kumar Loganathan   +6 more
wiley   +1 more source

Norroa™ as a dsRNA biopesticide for <i>Varroa destructor</i>: insights from New Zealand research on mode of action, field efficacy, non-target effects, and social acceptance. [PDF]

Front Insect Sci
Lester PJ, Bulgarella M, Manley B, Masucci JD, McGruddy RA, Merk J, Narva K, Palmer S, Mercier OR, Smeele ZE.   +9 more
europepmc   +1 more source